Faheem Hasnain
Chief Executive Officer bij GOSSAMER BIO, INC.
Vermogen: 7 M $ op 31-03-2024
Oorsprong van het eerstegraads netwerk van Faheem Hasnain
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
129
| Public Company | Pharmaceuticals: Major | 129 |
University of Windsor
79
| College/University | Other Consumer Services | 79 |
67
| Public Company | Pharmaceuticals: Major | 67 |
The Scripps Research Institute
 The Scripps Research Institute Other Consumer ServicesConsumer Services The Scripps Research Institute is a private, non-profit research organizations that performs basic biomedical research in molecular & cellular biology, chemistry, immunology and neuroscience. They receive the majority of its funding from federal agencies such as the National Institutes of Health. The organization also partners with pharmaceutical companies and is affiliated with the Scripps hospital group. The organization was founded in 1955 and is headquartered in La Jolla, California.
65
| College/University | Other Consumer Services | 65 |
| Public Company | Pharmaceuticals: Major | 55 | |
| Subsidiary | Biotechnology | 38 | |
| Public Company | Pharmaceuticals: Major | 29 | |
| Subsidiary | Pharmaceuticals: Major | 26 | |
| Public Company | Biotechnology | 24 | |
Vital Therapies, Inc.
 Vital Therapies, Inc. Pharmaceuticals: MajorHealth Technology Vital Therapies, Inc. operates as a biotherapeutic company, which develops a cell-based therapy targeting the treatment of acute forms of liver failure. Its product candidate, ELAD System, is a human cell-based bio-artificial liver support system that operates outside the body or extracorporeal. The company was founded in May 2003 and is headquartered in San Diego, CA.
20
| Extinct | Pharmaceuticals: Major | 20 |
20
| Subsidiary | Pharmaceuticals: Major | 20 |
| Extinct | Biotechnology | 15 | |
SENTÉ, Inc. (California)
 SENTÉ, Inc. (California) Specialty StoresRetail Trade SENTÉ, Inc. provides skin care products. The firm's products include Daily Repair Complex, Neck Firming and Redness Control Complex creams. It offers dermal repair cream for people of various age groups and skin types for enhancing the skin tone, texture, elasticity, and overall appearance. The company serves customers through dermatologists and physicians in the United States. Sente was founded by Kleanthis G. Xanthopoulos and Marios Fotiadis in 2007 and is headquartered in Carlsbad, CA.
15
| Holding Company | Specialty Stores | 15 |
Abbott Biotherapeutics Corp.
 Abbott Biotherapeutics Corp. Pharmaceuticals: MajorHealth Technology Abbott Biotherapeutics Corp. engages in the identification and development of oncology therapeutics. The firm's products in development include Daclizumab, a monoclonal antibody in Phase IIb clinical studies that binds to the alpha chain of the interleukin-2 receptor on activated T cells; and Volociximab, a chimeric monoclonal antibody in Phase I clinical studies that inhibits the functional activity of a protein in activated endothelial cells. The company was founded in 2008 and is headquartered in Redwood City, CA.
13
| Extinct | Pharmaceuticals: Major | 13 |
Aspen Neuroscience, Inc.
 Aspen Neuroscience, Inc. Medical/Nursing ServicesHealth Services Aspen Neuroscience, Inc. engages in the provision of neurological treatment services. It offers technologies for patient-specific induced pluripotent stem cell-based therapies. The company was founded by Jeanne Loring and is headquartered in San Diego, CA.
12
| Holding Company | Medical/Nursing Services | 12 |
Somaxon Pharmaceuticals, Inc.
 Somaxon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company. The company focuses on the in-licensing, development and commercialization of proprietary branded products and product candidates to treat important medical conditions where there is an unmet medical need and high-level of patient dissatisfaction, currently in the central nervous system therapeutic area. Its product, Silenor, is indicated for the treatment of insomnia characterized by difficulty with sleep maintenance. Somaxon Pharmaceuticals was founded in August 2003 and is headquartered in Solana Beach, CA.
10
| Extinct | Pharmaceuticals: Major | 10 |
| Private Company | Biotechnology | 10 | |
Biogen Idec, Inc. (North Carolina)
 Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The private company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016.
9
| Subsidiary | Pharmaceuticals: Major | 9 |
Tercica, Inc.
 Tercica, Inc. Pharmaceuticals: MajorHealth Technology The Company's principal activity as a biopharmaceutical company is focused on the development and commercialization of products to improve endocrine health. Its first product, IncrelexTM (mecasermin {rDNA origin} injection), or recombinant human insulin-like growth factor-1 (rhIGF-1), is approved by the FDA for the treatment of severe Primary IGFD. The Company licensed the rights to develop, manufacture and commercialize Increlex from Genentech Inc.
9
| Extinct | Pharmaceuticals: Major | 9 |
Vertex Ventures HC
 Vertex Ventures HC Investment ManagersFinance Vertex Ventures HC (Vertex Ventures) is a venture capital subsidiary of Vertex Venture Holdings Ltd founded in 2014. The firm is headquartered in San Francisco, California.
9
| Subsidiary | Investment Managers | 9 |
Oncology Therapeutics Network Corp.
 Oncology Therapeutics Network Corp. Medical DistributorsDistribution Services Oncology Therapeutics Network Corp. distributes pharmaceuticals to oncologists. It also provides support services. The company was founded in 1990 and is headquartered in South San Francisco, CA.
9
| Extinct | Medical Distributors | 9 |
Seragon Pharmaceuticals, Inc.
 Seragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Seragon Pharmaceuticals, Inc. developes biopharmaceutical products for the treatment of estrogen receptor dependent breast cancer. The company was founded in 2013 and is headquartered in San Diego, CA.
7
| Subsidiary | Pharmaceuticals: Major | 7 |
Aragon Pharmaceuticals, Inc.
 Aragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aragon Pharmaceuticals, Inc. develops biopharmaceutical products, It offers a pipeline of new anti-endocrine therapies targeting the biology of hormone resistant cancers. The company was founded by Charles L. Sawyers and Michael Jung on May 1, 2009 and is headquartered in San Diego, CA.
6
| Subsidiary | Pharmaceuticals: Major | 6 |
Sling Therapeutics, Inc.
 Sling Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sling Therapeutics, Inc. is a company dedicated to developing impactful and high-quality clinical therapies for patients. Sling Therapeutics is located in Ann Arbor, MI and was founded by Gary D. Hammer. The company's pipeline includes linsitinib, an oral therapy being developed for thyroid eye disease (TED) that has established a safety profile through treatment of over 800 patients. The company is focused on bringing additional treatment options to patients, as well as the ophthalmology, endocrinology, and rare disease communities. Sling Therapeutics welcomes collaboration in this mission. The CEO is Ryan Zeidan.
5
| Holding Company | Miscellaneous Commercial Services | 5 |
Panacea Acquisition Corp.
 Panacea Acquisition Corp. Financial ConglomeratesFinance Panacea Acquisition Corp. is a blank check company with the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in April 2020 and is headquartered in San Francisco, CA.
4
| Extinct | Financial Conglomerates | 4 |
SENTÉ Labs
1
| Private Company | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Faheem Hasnain via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| HERON THERAPEUTICS, INC. | Biotechnology | Director of Finance/CFO Director/Board Member Director/Board Member | |
| AMGEN INC. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal Chief Tech/Sci/R&D Officer Director/Board Member Corporate Officer/Principal Sales & Marketing General Counsel | |
| CELGENE | Biotechnology | Chief Executive Officer Director/Board Member President Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Sales & Marketing Corporate Officer/Principal General Counsel Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member Corporate Officer/Principal | |
| BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer Director/Board Member | |
Anadys Pharmaceuticals, Inc.
 Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO Founder Director/Board Member Founder Investor Relations Contact | |
ARCH Venture Partners LLC
 ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners LLC is a Venture Capital firm founded in 1986. The firm is headquartered in Chicago with additional office in Dublin. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Analyst Private Equity Analyst | |
Metabasis Therapeutics, Inc.
 Metabasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Metabasis Therapeutics, Inc. engages in discovery, development and commercialization of novel drugs for metabolic diseases using the proprietary technology and the knowledge of processes and pathways within the liver that are useful for liver-selective drug targeting and treatment of metabolic diseases. Metabasis was incorporated in April 1997 and is headquartered in La Jolla, CA. | Pharmaceuticals: Major | Chief Executive Officer Founder Director of Finance/CFO | |
| FIVE PRIME THERAPEUTICS, INC. | Biotechnology | Director/Board Member General Counsel Director/Board Member Chief Tech/Sci/R&D Officer | |
| ZOGENIX, INC. | Pharmaceuticals: Major | Director/Board Member Founder Director of Finance/CFO Corporate Officer/Principal | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| SYNDAX PHARMACEUTICALS, INC. | Biotechnology | General Counsel Founder Chief Tech/Sci/R&D Officer | |
| TURG POIN | Pharmaceuticals: Major | Chairman Director/Board Member Chief Executive Officer | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Graduate Degree Doctorate Degree Undergraduate Degree Undergraduate Degree | |
| Stanford University | College/University | Corporate Officer/Principal Undergraduate Degree Doctorate Degree Graduate Degree | |
| University of Pennsylvania | College/University | Doctorate Degree Undergraduate Degree Masters Business Admin | |
Leerink Partners LLC
 Leerink Partners LLC Investment Banks/BrokersFinance Leerink Partners LLC is a full-service brokerage and investment banking firm headquartered in Boston, Massachusetts. The firm was founded by Jeffrey Leerink in 1995 and formerly known as SVB Securities LLC. They rebranded as Leerink Partners in 2023. The firm is a subsidiary of SVB Securities LLC. Leerink Partners provides institutional sales, equity research, institutional trading, and corporate finance and asset management services to the healthcare and technology industries. They offer superior execution capabilities in common stock, convertibles and derivatives with a singular focus on healthcare and a knowledge-led approach. | Investment Banks/Brokers | Consultant / Advisor Analyst-Equity Corporate Officer/Principal | |
Chiron Viagene, Inc.
 Chiron Viagene, Inc. Miscellaneous Commercial ServicesCommercial Services Chiron Viagene, Inc. provides technical services and life science research. The company is based in San Diego, CA. The company specializes in EMSA reagents and services, as well as producing innovative technology. The company was founded by Paul K. Laikind, David F. Hale, Jack W. Reich, Harry E. Gruber. Chiron Viagene was acquired by Chiron Corp. on October 03, 1995 for $135 million. | Miscellaneous Commercial Services | Founder Founder Director/Board Member | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Corporate Officer/Principal Doctorate Degree Undergraduate Degree | |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | College/University | Director/Board Member Undergraduate Degree Undergraduate Degree | |
California Institute of Technology
 California Institute of Technology Other Consumer ServicesConsumer Services California Institute of Technology provides education focusing on science, engineering, academia, business, and public service. The company was founded in 1891 and it is headquartered in Pasadena, CA. | College/University | Director/Board Member Doctorate Degree Doctorate Degree | |
| University of California, Berkeley | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree Undergraduate Degree Undergraduate Degree Corporate Officer/Principal Doctorate Degree | |
| University of California San Diego | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Graduate Degree | |
| University of California, Santa Barbara | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| University of San Diego | College/University | Director/Board Member Undergraduate Degree Graduate Degree | |
| AMBRX INC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member Founder | |
BIOCOM
 BIOCOM Miscellaneous Commercial ServicesCommercial Services BIOCOM provides scientific and technological services. The firm focuses that positively influence the growth of the life science industry, including capital formation, public policy, workforce development and scientific discovery and development. The company was founded in 1995 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Founder Corporate Officer/Principal Chairman Director/Board Member Director/Board Member Director/Board Member | |
National Academy of Sciences
 National Academy of Sciences Miscellaneous Commercial ServicesCommercial Services National Academy of Sciences operates as a private, nongovernmental institution that advises on issues related to science and technology. It provides independent, objective analysis and advice and conducts other activities to solve complex problems and inform public policy decisions. The firm also encourages education and research, recognize outstanding contributions to knowledge, and increase public understanding in matters of science. The company was founded on March 3, 1863 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Ardea Biosciences, Inc.
 Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member General Counsel | |
National Academy of Medicine (United States)
 National Academy of Medicine (United States) Miscellaneous Commercial ServicesCommercial Services The National Academy of Medicine (United States) is based in Washington and is focused on improving the health and well-being of individuals through various initiatives. These initiatives include the clinician well-being collaborative, which aims to accelerate the implementation of a national plan for health workforce well-being, and the development of a code of conduct for the use of artificial intelligence in health care. The organization also provides resources to support meaningful community engagement in health and health care programs and policies. Recently, the National Academy of Medicine announced the appointment of Mandy Cohen, a member of the organization, as the director of the Centers for Disease Control and Prevention. Additionally, the organization has released a publication celebrating 50 years of progress in biomedical science, health, and health care. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
CONNECT
 CONNECT Miscellaneous Commercial ServicesCommercial Services CONNECT creates and scales companies in the technology and life sciences sectors. It creates an environment in which entrepreneurs and C-suite executives have access to the people, capital, and technology resources. The organization was founded in 1985 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Founder Director/Board Member Director/Board Member | |
| REGULUS THERAPEUTICS INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Director/Board Member Chairman Director/Board Member | |
| KARA THER | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member President | |
| Harvard Law School | College/University | Graduate Degree Graduate Degree Graduate Degree | |
Yumanity, Inc.
 Yumanity, Inc. Pharmaceuticals: MajorHealth Technology Yumanity, Inc. engages in transforming drug discovery for neurodegenerative diseases services. It provides integrated discovery platforms, phenotypic screening (uHTS) platforms, in which different protein misfolding pathologies are modeled in yeast to help discover compounds to correct these pathologies; a human neuronal platform. The company was founded by Anthony N. Coles, Jr. and Susan L. Lindquist in December 2014 and is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Vividion Therapeutics, Inc.
 Vividion Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Vividion Therapeutics, Inc. operates as a biotechnology company. The company focuses on developing innovative therapeutics that treat major unmet clinical needs using the first platform for proteome wide drug and target discovery. It's proprietary chemoproteomic platform technology addresses the key limitations of conventional screening techniques and allows the discovery of previously unknown, or cryptic, functional pockets on the surface of proteins and identification of small molecules that selectively bind to those targets. The company was founded by Benjamin F. Cravatt, Phil S. Baran, Jin-Quan Yu and John K. Clarke on December 24, 2013 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
UC San Diego Foundation
 UC San Diego Foundation Investment Trusts/Mutual FundsMiscellaneous UC San Diego Foundation specializes in obtaining private gifts in support of research, teaching, and public service, as well as engages in management of gift assets. The company is was founded in 1972 and is headquartered in La Jolla, CA. | Investment Trusts/Mutual Funds | Director/Board Member Director/Board Member Director/Board Member | |
| BOUNDLESS BIO, INC. | Biotechnology | Comptroller/Controller/Auditor Founder Director/Board Member General Counsel Director/Board Member | |
| RAYZEBIO, INC. | Biotechnology | Chairman Corporate Officer/Principal Director/Board Member Director/Board Member | |
| ENLIVEN THERAPEUTICS, INC. | Biotechnology | Chairman Director/Board Member Chief Tech/Sci/R&D Officer |
Statistieken
Internationaal
| Verenigde Staten | 49 |
| Ierland | 2 |
| België | 2 |
Sectoraal
| Health Technology | 27 |
| Consumer Services | 11 |
| Commercial Services | 8 |
| Finance | 5 |
| Miscellaneous | 3 |
Operationeel
| Director/Board Member | 635 |
| Corporate Officer/Principal | 248 |
| Independent Dir/Board Member | 223 |
| Chairman | 168 |
| Chief Executive Officer | 120 |
Sterkste connecties
| Insiders | |
|---|---|
| David Hale | 54 |
| Kristina Burow | 40 |
| Muneer Satter | 35 |
| Thomas Daniel | 35 |
| Kurt von Emster | 34 |
| Richard Heyman | 33 |
| Alan J. Lewis | 33 |
| Michael Grey | 32 |
| Paul Schimmel | 31 |
| Thomas Wiggans | 31 |
| David Parkinson | 31 |
| Kleanthis Xanthopoulos | 29 |
| Lori Kunkel | 27 |
| Stelios Papadopoulos | 26 |
| Bruce Carter | 25 |
- Beurs
- Insiders
- Faheem Hasnain
- Bedrijfsconnecties
